Jpmorgan Chase & CO Bausch & Lomb Corp Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.8 - $20.99 $105,840 - $132,237	6,300 Added 5.0%	132,176 $2.24 Million
Q2 2023 Aug 11, 2023	SELL	$16.03 - $20.07 $35,714 - $44,715	-2,228 Reduced 1.74%	125,876 $2.53 Million
Q1 2023 May 11, 2023	BUY	$15.67 - $18.91 $36,338 - $43,852	2,319 Added 1.84%	128,104 $2.23 Million
Q4 2022 Feb 13, 2023	BUY	$13.5 - $17.14 $1.7 Million - $2.16 Million	125,785 New	125,785 $1.95 Million
Q2 2022 Aug 11, 2022	BUY	$13.36 - $20.0 $6,626 - $9,920	496 New	496 $8,000

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.25B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.